Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | NK1 antagonist for chemotherapy nausea, especially delayed vomiting. | Powerful anti-sickness medicine. |
| Body system | Stomach & Gut | Stomach & Gut |
| Drug class | NK1 antagonists | 5-HT3 antagonists |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Chemotherapy-induced nausea and vomiting, Postoperative nausea and vomiting | Chemotherapy and radiotherapy nausea, Nausea after surgery, Gastroenteritis vomiting (children, single dose), Severe pregnancy sickness (second line) |
| How it works | Blocks a brain signal that triggers delayed vomiting. | Blocks serotonin signals that trigger vomiting. |
| Starts working | Within hours | 30 minutes |
| Half-life | 9–13 hours | 3–6 hours |
| Typical adult dose | 125 mg 1 hour before chemotherapy on day 1, then 80 mg on days 2 and 3. | 4–8 mg up to three times a day (higher with chemotherapy). |
| Forms | Capsule, IV injection (fosaprepitant) | Tablet, Orodispersible tablet or film, Oral solution, Injection |
| Common side effects | Tiredness, Constipation, Hiccups, Reduced appetite | Constipation, Headache, Warmth or flushing |
| Serious side effects | Allergic reactions, Liver enzyme rise | QT prolongation, Serotonin syndrome with other serotonergic drugs (rare) |
| Don't take if | Taking pimozide; Taking cisapride | Known long QT syndrome; Taking apomorphine; Allergy to ondansetron |
| Alcohol | Usually no problem in moderation. No specific interaction. | Usually no problem in moderation. No specific interaction. |
| Pregnancy | Use with cautionLimited data. | Use with cautionA small increase in cleft palate is possible with first-trimester use; may be used if first-line options fail. |
| Breastfeeding | Usually avoidedAvoid. | Use with cautionLimited data; avoid in the first trimester unless needed. |
| In use since | — | 1991 |
| Brand names | United States: Emend, CinvantiUnited Kingdom: EmendIndia: Emend, Aprecap, Fosprepitant (generic) | United States: ZofranUnited Kingdom: ZofranIndia: Emeset, Ondem, Vomikind |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A04AD12 | A04AA01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker